CHEMED CORP (CHE) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:CHE - US16359R1032 - Common Stock
432.18 USD
-3.1 (-0.71%)
432.18 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 88% to CHE. The Buy consensus is the weighted average rating of the current analysts ratings.
CHE was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about CHE.
In the previous month the buy percentage consensus was at a similar level.
CHE was analyzed by 8 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-02 | Jefferies | Upgrade | Hold -> Buy |
| 2025-07-31 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-25 | Jefferies | Initiate | Hold |
| 2025-06-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-30 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-03-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-05-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-01-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-01 | RBC Capital | Maintains | Outperform |
| 2023-04-28 | Oppenheimer | Maintains | Outperform |
| 2023-02-27 | RBC Capital | Maintains | Outperform |
| 2022-11-03 | RBC Capital | Maintains | Outperform |
| 2022-08-01 | RBC Capital | Maintains | Outperform |
| 2022-04-28 | RBC Capital | Maintains | Outperform |
| 2022-03-04 | RBC Capital | Maintains | Outperform |
| 2021-07-29 | RBC Capital | Maintains | Outperform |
| 2021-02-25 | Oppenheimer | Maintains | Outperform |
CHEMED CORP / CHE FAQ
What is the consensus rating for CHE stock?
The consensus rating for CHEMED CORP (CHE) is 87.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for CHEMED CORP stock?
The number of analysts covering CHEMED CORP (CHE) is 8.